Patients with advanced follicular lymphoma (FL) have numerous treatment options,
including observation, radiotherapy, single-agent or combination chemotherapy, mAbs, and …

Background Among the 566 patients with follicular lymphomas (FL) included in the GELF 86
prospective trials from October 1986 to September 1995, 372 with progressive/relapsing …

Autologous and Allogeneic Stem-Cell Transplantation for Transformed Follicular Lymphoma: A
Report of the Canadian Blood and Marr Page 1 Autologous and Allogeneic Stem-Cell …

The aim of this project was to define indications for hematopoietic stem cell transplantation
in follicular lymphoma in Europe. In the absence of evidence-based data, a RAND-modified …

Although chemoimmunotherapy improves outcomes for patients with follicular lymphoma
(FL), approximately 20% of patients experience early disease progression within two years …

BACKGROUND Allogeneic hematopoietic stem cell transplantation (allo‐HCT) remains the
only potentially curative treatment option for relapsed follicular lymphoma (FL), yet questions …

Disease overview: Follicular lymphoma (FL) is generally an indolent B‐cell
lymphoproliferative disorder of transformed follicular center B cells. FL is characterized by …

Doxorubicin-based immunochemotherapy, with interferon, has been shown to improve
survival in patients with advanced follicular lymphoma. High-dose chemotherapy with stem …

This prospective phase II study was undertaken to evaluate the efficacy and toxicity of early
intensive therapy followed by purged autologous bone marrow transplantation (ABMT) in …

Autologous stem-cell transplantation (ASCT) has been used in follicular lymphoma (FL) to
achieve durable responses in first remission or in the relapsed or refractory settings …